ZVRA: Zevra Therapeutics, Inc.
Performance
ZVRA +37.80%
Watchlist
Select an item
Summary
ZVRA at a glance
ZVRA returned +37.80% over the past year and +5.10% a year over five years. Its worst drop in that year was -35.53%, smaller than 46% of stocks on Redstone, and its Sharpe ratio of 0.77 beats 65% of stocks on Redstone. It pays no dividends.
Current Drawdown
-17.69%
Rolling Volatility
69.70%
Actions
Metrics
Risk Indicators
Alpha36.99%
Beta1.01x
Sharpe0.77
Sortino1.18
Omega1.16
Calmar1.06
Martin2.86
Profile
About ZVRA
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $722M
- Listed
- Apr 2015
- Employees
- 61
- Headquarters
- Boston, MA
- Website
- zevra.com
Comparisons